Physician

Molly S Stumacher, MD

According to 2025 Medicare claims, Molly Stumacher, MD (NPI: 1396842126) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (NPI: 1841226099; TIN: 23-1714249) and primary practice location at 19010-3200. Stumacher is affiliated with the Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Stumacher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 692 traditional Medicare patients, billed 248,523 HCPCS/CPT codes, and received $3,563,034 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,512 prescription claims across 320 beneficiaries totaling $2,342,670 in drug costs, led by Verzenio (Abemaciclib). DME data shows 76 claims. Open Payments data shows 114 records totaling $2,339. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $70,242 to $3,563,034. Similarly, Part D prescription costs have moved sharply higher in recent years, from $244,403 to $2,342,670. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,261 to $5,144.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	299	838	$70,242
2016	372	976	$80,231
2017	366	978	$76,585
2018	417	25,957	$378,789
2019	365	122,937	$1,238,064
2020	369	141,178	$1,570,452
2021	455	188,579	$1,599,824
2022	476	232,885	$2,142,795
2023	529	262,045	$2,095,403
2024	692	248,523	$3,563,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	114	580	$244,403
2016	115	610	$472,841
2017	121	590	$607,953
2018	131	540	$560,422
2019	123	562	$732,618
2020	141	727	$716,889
2021	182	867	$774,109
2022	228	1,127	$885,814
2023	255	1,213	$786,324
2024	320	1,512	$2,342,670

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	68	$1,586
2016	N/R	N/R	N/R
2017	N/R	51	$950
2018	N/R	53	$979
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	27	$909
2023	N/R	N/R	N/R
2024	N/R	76	$2,730

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	98	154	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	539	1,102	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	105	$68
96372	Injection of drug or substance under skin or into muscle	100	541	$11
36415	Insertion of needle into vein for collection of blood sample	110	733	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	22	616	$362,342
Revlimid	Lenalidomide	23	532	$330,686
Ibrance	Palbociclib	16	448	$284,811
Calquence	Acalabrutinib Maleate	12	360	$185,529
Eliquis	Apixaban	107	4,710	$90,494

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	14	$1,577
J8700	Temozolomide, oral, 5 mg	N	N/R	12	$602
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	25	$314
E1038	Transport chair, adult size, patient weight capacity up to and including 300 pounds	Y	N/R	25	$237

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	114	$2,339	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Molly S. Stumacher, MD?

Tedicare shows public-source Medicare data for Molly S. Stumacher, MD (NPI 1396842126), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Molly S. Stumacher, MD have ACO affiliation data?

Molly S. Stumacher, MD is shown with ACO affiliation data for Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to Molly S. Stumacher, MD?

Molly S. Stumacher, MD is linked to BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (billing NPI 1841226099) in the available physician profile data.

Does Molly S. Stumacher, MD have Open Payments data?

Molly S. Stumacher, MD has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.